http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022150851-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fd8b3f7e448b46bd727daca75a866d2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17 |
| filingDate | 2022-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ba12fe9e872d9fce9e75b2a63f752d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4a4a3e4940b53b1d02c906e0d2fd3c4 |
| publicationDate | 2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022150851-A2 |
| titleOfInvention | Treatment of brain metastases and cns metastases using illudins or hydroxylureamethyl acylfulvene |
| abstract | This application discloses methods for treating a cancer that has metastasized to the brain in a subject using a therapeutically effective amount of HydroxyUreaMethyl Acylfulvene. In addition, pharmaceutical compositions having HydroxyUreaMethyl Acylfulvene and a pharmaceutically acceptably carrier, diluent, excipient, or a combination thereof are disclosed. |
| priorityDate | 2021-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.